HOLMDEL, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM) solutions, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the exercise of certain outstanding warrants that the Company issued on January 15 2025. Pursuant to the warrant inducement agreement, the investor has agreed to exercise the outstanding Series A and Series B Warrants to purchase an aggregate of 3,091,668 shares of the Company’s common stock at a reduced exercise price of $1.02 per share, subject to compliance with beneficial ownership blocker provisions included in the warrants. The gross proceeds from the exercise of the warrants are expected to be approximately $3.1 million, prior to deducting placement agent fees and estimated offering expenses.
HOLMDEL, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM) solutions, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the exercise of certain outstanding warrants that the Company issued on January 15 2025. Pursuant to the warrant inducement agreement, the investor has agreed to exercise the outstanding Series A and Series B Warrants to purchase an aggregate of 3,091,668 shares of the Company’s common stock at a reduced exercise price of $1.02 per share, subject to compliance with beneficial ownership blocker provisions included in the warrants. The gross proceeds from the exercise of the warrants are expected to be approximately $3.1 million, prior to deducting placement agent fees and estimated offering expenses. Nasdaq:BKYI, US09060C3097
